Asymchem Laboratories (Tianjin) Co., Ltd. Stock OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 54.6B 8.12B 6.96B 6.51B 5.95B 11.23B 778B 11.35B 77.05B 29.96B 391B 30.49B 29.83B 1,292B | P/E 2026 * |
40.6x | P/E 2027 * | 31.9x |
|---|---|---|---|---|---|
| Enterprise Value | 50.32B 7.49B 6.41B 6B 5.49B 10.35B 717B 10.46B 71.01B 27.61B 360B 28.11B 27.5B 1,191B | EV / Sales 2026 * |
6.2x | EV / Sales 2027 * | 5.18x |
| Free-Float |
61.13% | Yield 2026 * |
0.73% | Yield 2027 * | 1.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 1998-10-06 |
Rui Yang
CEO | Chief Executive Officer | 49 | 2022-01-18 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 8.12B | ||
| -0.67% | +5.39% | +75.21% | +127.54% | 1,111B | ||
| +1.04% | +4.07% | +52.29% | +65.39% | 658B | ||
| -0.17% | +5.67% | +25.60% | +80.40% | 467B | ||
| +0.15% | +2.83% | +42.79% | +43.17% | 369B | ||
| 0.00% | +1.05% | +25.33% | +41.42% | 301B | ||
| +0.18% | +2.74% | +2.17% | +13.79% | 256B | ||
| +1.03% | +5.83% | +51.11% | +72.96% | 240B | ||
| +2.01% | +2.92% | -16.96% | -52.27% | 207B | ||
| +0.42% | +5.63% | +27.86% | +92.24% | 182B | ||
| Average | +0.41% | +4.49% | +31.71% | +53.85% | 421.22B | |
| Weighted average by Cap. | +0.19% | +4.68% | +44.25% | +73.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.12B 1.21B 1.03B 968M 885M 1.67B 116B 1.69B 11.46B 4.45B 58.06B 4.53B 4.44B 192B | 9.72B 1.45B 1.24B 1.16B 1.06B 2B 138B 2.02B 13.71B 5.33B 69.49B 5.43B 5.31B 230B |
| Net income | 1.42B 211M 181M 169M 155M 292M 20.19B 295M 2B 778M 10.14B 792M 775M 33.55B | 1.77B 263M 225M 211M 193M 364M 25.17B 367M 2.49B 970M 12.64B 987M 966M 41.82B |
| Net Debt | -4.28B -636M -545M -510M -466M -880M -60.93B -889M -6.04B -2.35B -30.59B -2.39B -2.34B -101B | -4.28B -637M -546M -511M -467M -881M -60.98B -890M -6.04B -2.35B -30.62B -2.39B -2.34B -101B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















